U.S. Representatives have reintroduced the Food Chemical Reassessment Act of 2025 to Congress, which would require FDA to reevaluate the safety of chemicals—including “Generally Recognized as Safe” (GRAS) substances, food dyes, and food contact substances—every three years.
On May 2, the U.S. Office of Management and Budget sent a discretionary budget request for fiscal year 2026 from the Trump Administration to Congress. The request includes funds to build up the MAHA Commission.
Introduced by Senator Cindy Hyde-Smith (R-MS), the Senate Bill 667, named the Safer Shrimp Imports Act, would require FDA to ensure that food safety inspections for shrimp in importing countries meet standards equivalent to those upheld in the U.S.
A partisan letter signed by 85 members of Congress has been sent to President Trump, expressing concerns about the communications freeze ordered for public health agencies like CDC and FDA, especially in light of the ongoing avian influenza H5N1 outbreak.
Recently reintroduced to Congress, the bipartisan Protect Infant Formula From Contamination Act aims to strengthen FDA’s oversight of infant formula manufacturers by expanding certain authorities, allowing the agency to better ensure the safety and resiliency of the country’s infant formula supply.
Reintroduced to U.S. Congress on February 3, the Expanded Food Safety Investigation Act seeks to grant FDA the authority to collect microbial samples from concentrated animal feeding operations, also referred to as “factory farms,” during foodborne illness outbreak investigations.
A letter signed by four U.S. senators was recently sent to Jim Jones, FDA Deputy Commissioner for Human Foods, about the agency’s plans for reduced funding for state and local food safety programs, which could significantly affect inspections.
Boar’s Head has responded to a letter from 22 members of Congress probing the company about the recent, fatal listeriosis outbreak linked to its products. Representative Rosa DeLauro (D-CT), who signed the letter, called Boar’s Head’s response “not credible” and “a classic corporate dodge.”
In a recent Senate hearing, top U.S. Food and Drug Administration (FDA) officials shared how resource constraints hinder its food chemical safety review work, and provided insight into a pending decision about red dye 3’s authorization for food use.
A letter written to the U.S. Food and Drug Administration (FDA) by 23 members of Congress urges the agency to ban from food use red dye 3, a controversial synthetic colorant that is potentially harmful to human health.
